Login / Signup

Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study.

Dirk SchadendorfA HauschildS FoskoD ZlotyB LabeilleJ-J GrobS PuigM MakrutzkiF GilbergA HongBrigitte DrenoG RogersR Kunstfeld
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Keyphrases
  • patient reported
  • basal cell carcinoma
  • single cell
  • cell therapy
  • high grade
  • high intensity
  • stem cells
  • mesenchymal stem cells